(Total Views: 475)
Posted On: 01/08/2022 11:00:30 AM
Post# of 145247
Wasn't the CRO, Amarex, responsible for tracking the patients and recording the data from the trial? Have they turned over the data yet? I don't believe so, and if not, that would easily explain why NP said they may have to contact the patients to determine their current status.
Quote:
not staying on top of the survival rate for the past 4 months was a bit of a surprise, and that is an understatement . symptom of two many balls in the air and a stretched staff perhaps ?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
My comments are just my opinions and should NOT be taken as investment advice.